Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Toxic Epidermal Necrolysis: Does Immunoglobulin Make a Difference?
K. M. Brown
, G. M. Silver
, M. Halerz
, P. Walaszek
, A. Sandroni
, Richard L. Gamelli
Research output
:
Contribution to journal
›
Article
›
peer-review
156
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Toxic Epidermal Necrolysis: Does Immunoglobulin Make a Difference?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Immunoglobulin
100%
Toxic Epidermal Necrolysis
100%
Toxic Epidermal Necrolysis Syndrome
68%
Immunoglobulin Therapy
31%
SCORTEN
25%
Length of Stay
18%
Malignancy
12%
Fas Ligand
12%
Survivors
6%
In Vitro Study
6%
Clinical Trials
6%
Heart Rate
6%
Overall Mortality
6%
Single Institution
6%
Blood Glucose
6%
Bicarbonate
6%
HCO3
6%
Anecdotal Evidence
6%
No Significant Difference
6%
Retrospective Chart Review
6%
Burn Center
6%
Randomized Trial
6%
Patient Outcomes
6%
Successful Treatment
6%
Glucose Level
6%
Biopsy-proven
6%
Ligand-mediated
6%
Blood Urea Nitrogen
6%
Bicarbonate Levels
6%
Prognosis Prediction
6%
Institutional Control
6%
Large Series
6%
Significant Benefit
6%
SCORTEN Score
6%
Severity Level
6%
Keratinocyte Apoptosis
6%
Severity of Illness Score
6%
Pharmacology, Toxicology and Pharmaceutical Science
Immunoglobulin
100%
Toxic Epidermal Necrolysis
100%
Syndrome
68%
Immunotherapy
31%
Fas Ligand
12%
Clinical Trial
6%
Burn
6%
Dicarbonate
6%
Ureaplasma
6%
Diseases
6%
Medicine and Dentistry
Immunoglobulin
100%
Toxic Epidermal Necrolysis
100%
Immunotherapy
31%
Cancer
12%
Fas Ligand
12%
Blood Urea Nitrogen
12%
Clinical Trial
6%
Thermal Burn
6%
In Vitro
6%
Programmed Cell Death
6%
Sodium Bicarbonate
6%
Biopsy Technique
6%
Diseases
6%
Keratinocyte
6%